Fosfonat nükleotid analoglarının ön ilaçları, bunların seçimi-yapımı için yöntemler

• Main Authors: HARLAN H. CHAPMAN, JOHN C. ROHLOFF, GONG-XIN HE, TOMAS CIHLAR, MICHAEL R. KERNAN, MARK L. SPARACINO, MARK W. BECKER, EUGENE J. EISENBERG, ERNEST J. PRISBE, WILLIAM A. LEE
• Format: Patent
• Language: Turkish
• Published: 21.12.2004
• Edition: 7
• Subjects: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM; BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; DERIVATIVES THEREOF; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; NUCLEIC ACIDS; NUCLEOSIDES; NUCLEOTIDES; ORGANIC CHEMISTRY; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; SUGARS; TESTING; VINEGAR; WINE

Antiviral ya da antitümör etkinin istendigi dokulari selektif olarak hedef alan ön ilaçlarin belirlenmesi için metoksifosfonat nükleotit analoglarinin ön ilaçlarinin taranmasindan olusan yeni bir yöntem sunulmaktadir. Bu yöntem, burada tanimlanan ikame gruplarini tasiyan formül yapisina (5a) sahip bilesikler de dahil olmak üzere, retroviral ya da hepadnaviral tedavi için yeni PMPA ester-amidat karisiminin tanimlanmasini saglamistir. Farmakolojik olarak kabul edilebilir katki maddeleri içindeki bu yeni bilesiklerin bilesimleri ve bunlarin tedavide ve profilakside kullanimi sunulmaktadir. Bunun yani sira, baslangiç maddelerinin ve burada kullanilmak üzere bilesiklerin hazirlanmasinda magnezyum alkoksit kullanimi için gelismis bir yöntem sunulmaktadir.Formül (5a) A novel method is provided for screening prodrugs of methoxyphosphonate nucleotide analogues to identify prodrugs selectively targeting desired tissues with antiviral or antitumor activity. This method has led to the identification of novel mixed ester-amidates of PMPA for retroviral or hepadnaviral therapy, including compounds of structure (5a) having substituent groups as defined herein. Compositions of these novel compounds in pharmaceutically acceptable excipients and their use in therapy and prophylaxis are provided. Also provided is an improved method for the use of magnesium alkoxide for the preparation of starting materials and compounds for use herein.